middle.news
Control Bionics Drives Record US Revenue and Expands Global Footprint in Q3 FY25
5:34am on Monday 2nd of June, 2025 AEST
•
Healthcare
Read Story
Control Bionics Drives Record US Revenue and Expands Global Footprint in Q3 FY25
5:34am on Monday 2nd of June, 2025 AEST
Key Points
US revenue up 20% over six months, highest since FY23
Australia achieves best quarterly revenue since 2022 with improved NDIS approvals
Launch of NeuroStrip cloud software introduces new SaaS revenue stream
Completed investment in Neuro Elite Athletics with promising sports science outcomes
Read Story
middle.
Tap to Read
Tap the card to read the full analysis
about
Control Bionics (ASX:CBL)
OPEN ARTICLE